
|Videos|November 13, 2015
Stopping Memantine or Cholinesterase in Dementia Patients
Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.
Advertisement
Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.
This video was recorded at ASCP's Annual Meeting and Exhibition in Las Vegas, Nevada in October 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
PBM Reform Within 2026 Appropriations Bill Signed Into Law
2
Most Favored Nation Drug Pricing: Analysis and Implications
3
Study Finds Persistent Gaps in Diagnoses for Depression and Chronic Conditions After COVID-19
4
From CAR T to Gene Therapy, Pharmacists Prepare for What’s Next at the 2026 Tandem Meeting
5


























